BIOXCEL THERAPEUTICS INC. - COMMON STOCK
1.0600
05-July-24 12:27:39
15 minutes delayed
Stocks
-0.0200
-1.85%
Today's range
1.0350 - 1.1200
ISIN
N/A
Source
NASDAQ
-
BioXcel Therapeutics to Present at Jefferies Global Healthcare Conference
28 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
21 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics Reports First Quarter 2024 Financial Results
09 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report First Quarter 2024 Financial Results on May 9, 2024
25 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
22 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
10 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics Announces $25 Million Registered Direct Offering
25 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
15 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
12 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
01 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics Announces Termination of Proposed Public Offering
13 Feb 2024 09:00:43 By Nasdaq GlobeNewswire
-
12 Feb 2024 07:14:31 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics Announces Proposed Public Offering
08 Feb 2024 16:01:00 By Nasdaq GlobeNewswire
-
05 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day Today
12 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics Strengthens Clinical Development Leadership to Advance Late-Stage Programs
11 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Host Virtual Neuroscience R&D Day on Dec. 12, 2023
30 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >